A murderer of young bladders

Ketamine-associated cystitis

En Meng, Sheng Tang Wu, Tai Lung Cha, Guang Huan Sun, Dah Shyong Yu, Sheng Yran Chang

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

The use of ketamine as a recreational drug, particularly among teenagers, has increased dramatically in the past few years in Taiwan. Its effects on the central nervous and cardiovascular systems are well characterized, but an increasing amount of evidence demonstrates its association with urinary tract pathologies. Chronic ketamine use has been associated with severe ulcerative cystitis. Symptoms and signs of long-term ketamine abuse include: hematuria; increased voiding frequency; urgency; bladder pain; dysuria; nocturia; decreased bladder capacity; urothelial ulceration, and eosinophil infiltration. Vesicoureteral reflux and renal function impairment may also occur in heavy ketamine users. How ketamine use produces these symptoms is not clear. Dysregulation of purinergic neurotransmission has recently been found to play a role in the detrusor overactivity in ketamine-induced bladder dysfunction. The goal of treatment is to prevent deterioration of the renal function and indeed offer the possibility of symptom resolution. Currently, ketamine cessation is the only effective treatment modality, but the effect is likely to be dependent on the severity and duration of the abuse. Anticholinergic agents fail to relieve the symptoms induced by chronic ketamine use. Intravesical hyaluronan solution instillation may help improve the symptoms, but more clinical studies are required to provide evidence of the effectiveness. A multidisciplinary treatment team of doctors, psychiatrists, nurses, therapists, and clinicians will facilitate best practice management of patients with ketamine-associated cystitis.

Original languageEnglish
Pages (from-to)113-116
Number of pages4
JournalUrological Science
Volume24
Issue number4
DOIs
Publication statusPublished - Jan 1 2013
Externally publishedYes

Fingerprint

Cystitis
Ketamine
Urinary Bladder
Nocturia
Nurse Clinicians
Kidney
Dysuria
Vesico-Ureteral Reflux
Practice Management
Cholinergic Antagonists
Street Drugs
Hematuria
Hyaluronic Acid
Cardiovascular System
Urinary Tract
Taiwan
Practice Guidelines
Eosinophils
Synaptic Transmission
Signs and Symptoms

Keywords

  • Cystitis
  • Ketamine
  • Urinary bladder

ASJC Scopus subject areas

  • Urology

Cite this

A murderer of young bladders : Ketamine-associated cystitis. / Meng, En; Wu, Sheng Tang; Cha, Tai Lung; Sun, Guang Huan; Yu, Dah Shyong; Chang, Sheng Yran.

In: Urological Science, Vol. 24, No. 4, 01.01.2013, p. 113-116.

Research output: Contribution to journalReview article

Meng, En ; Wu, Sheng Tang ; Cha, Tai Lung ; Sun, Guang Huan ; Yu, Dah Shyong ; Chang, Sheng Yran. / A murderer of young bladders : Ketamine-associated cystitis. In: Urological Science. 2013 ; Vol. 24, No. 4. pp. 113-116.
@article{1f356dad8d644826b8d988de5f8d6bab,
title = "A murderer of young bladders: Ketamine-associated cystitis",
abstract = "The use of ketamine as a recreational drug, particularly among teenagers, has increased dramatically in the past few years in Taiwan. Its effects on the central nervous and cardiovascular systems are well characterized, but an increasing amount of evidence demonstrates its association with urinary tract pathologies. Chronic ketamine use has been associated with severe ulcerative cystitis. Symptoms and signs of long-term ketamine abuse include: hematuria; increased voiding frequency; urgency; bladder pain; dysuria; nocturia; decreased bladder capacity; urothelial ulceration, and eosinophil infiltration. Vesicoureteral reflux and renal function impairment may also occur in heavy ketamine users. How ketamine use produces these symptoms is not clear. Dysregulation of purinergic neurotransmission has recently been found to play a role in the detrusor overactivity in ketamine-induced bladder dysfunction. The goal of treatment is to prevent deterioration of the renal function and indeed offer the possibility of symptom resolution. Currently, ketamine cessation is the only effective treatment modality, but the effect is likely to be dependent on the severity and duration of the abuse. Anticholinergic agents fail to relieve the symptoms induced by chronic ketamine use. Intravesical hyaluronan solution instillation may help improve the symptoms, but more clinical studies are required to provide evidence of the effectiveness. A multidisciplinary treatment team of doctors, psychiatrists, nurses, therapists, and clinicians will facilitate best practice management of patients with ketamine-associated cystitis.",
keywords = "Cystitis, Ketamine, Urinary bladder",
author = "En Meng and Wu, {Sheng Tang} and Cha, {Tai Lung} and Sun, {Guang Huan} and Yu, {Dah Shyong} and Chang, {Sheng Yran}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.urols.2013.09.001",
language = "English",
volume = "24",
pages = "113--116",
journal = "Urological Science",
issn = "1879-5226",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - A murderer of young bladders

T2 - Ketamine-associated cystitis

AU - Meng, En

AU - Wu, Sheng Tang

AU - Cha, Tai Lung

AU - Sun, Guang Huan

AU - Yu, Dah Shyong

AU - Chang, Sheng Yran

PY - 2013/1/1

Y1 - 2013/1/1

N2 - The use of ketamine as a recreational drug, particularly among teenagers, has increased dramatically in the past few years in Taiwan. Its effects on the central nervous and cardiovascular systems are well characterized, but an increasing amount of evidence demonstrates its association with urinary tract pathologies. Chronic ketamine use has been associated with severe ulcerative cystitis. Symptoms and signs of long-term ketamine abuse include: hematuria; increased voiding frequency; urgency; bladder pain; dysuria; nocturia; decreased bladder capacity; urothelial ulceration, and eosinophil infiltration. Vesicoureteral reflux and renal function impairment may also occur in heavy ketamine users. How ketamine use produces these symptoms is not clear. Dysregulation of purinergic neurotransmission has recently been found to play a role in the detrusor overactivity in ketamine-induced bladder dysfunction. The goal of treatment is to prevent deterioration of the renal function and indeed offer the possibility of symptom resolution. Currently, ketamine cessation is the only effective treatment modality, but the effect is likely to be dependent on the severity and duration of the abuse. Anticholinergic agents fail to relieve the symptoms induced by chronic ketamine use. Intravesical hyaluronan solution instillation may help improve the symptoms, but more clinical studies are required to provide evidence of the effectiveness. A multidisciplinary treatment team of doctors, psychiatrists, nurses, therapists, and clinicians will facilitate best practice management of patients with ketamine-associated cystitis.

AB - The use of ketamine as a recreational drug, particularly among teenagers, has increased dramatically in the past few years in Taiwan. Its effects on the central nervous and cardiovascular systems are well characterized, but an increasing amount of evidence demonstrates its association with urinary tract pathologies. Chronic ketamine use has been associated with severe ulcerative cystitis. Symptoms and signs of long-term ketamine abuse include: hematuria; increased voiding frequency; urgency; bladder pain; dysuria; nocturia; decreased bladder capacity; urothelial ulceration, and eosinophil infiltration. Vesicoureteral reflux and renal function impairment may also occur in heavy ketamine users. How ketamine use produces these symptoms is not clear. Dysregulation of purinergic neurotransmission has recently been found to play a role in the detrusor overactivity in ketamine-induced bladder dysfunction. The goal of treatment is to prevent deterioration of the renal function and indeed offer the possibility of symptom resolution. Currently, ketamine cessation is the only effective treatment modality, but the effect is likely to be dependent on the severity and duration of the abuse. Anticholinergic agents fail to relieve the symptoms induced by chronic ketamine use. Intravesical hyaluronan solution instillation may help improve the symptoms, but more clinical studies are required to provide evidence of the effectiveness. A multidisciplinary treatment team of doctors, psychiatrists, nurses, therapists, and clinicians will facilitate best practice management of patients with ketamine-associated cystitis.

KW - Cystitis

KW - Ketamine

KW - Urinary bladder

UR - http://www.scopus.com/inward/record.url?scp=84889610345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889610345&partnerID=8YFLogxK

U2 - 10.1016/j.urols.2013.09.001

DO - 10.1016/j.urols.2013.09.001

M3 - Review article

VL - 24

SP - 113

EP - 116

JO - Urological Science

JF - Urological Science

SN - 1879-5226

IS - 4

ER -